Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF vs betamethasone vs saline for work-related epicondylitis refractory to conservative treatment (Phase III)
2017-001249-28Phase 3Active
- Sponsor
- Mutua Universal
- Start
- Aug 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of PRGF-Endoret in epicondylitis (3 arms), sponsored by Mutua Universal. Started Aug 2018; status: active.
02
Drugs
PRGF-Endoret
03
Conditions
epicondylitis
Beyond the preview
Go deeper on 2017-001249-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001249-28.